Search

Search Constraints

You searched for: Author/Creator Faehling, Martin

Search Results

1. Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3, 000 Heidelberg cases. Issue 3 (19th February 2019)

3. Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program. (February 2021)

4. Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer. (March 2021)

5. The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions. (July 2022)

6. Real-world multicentre analysis of neoadjuvant immunotherapy and chemotherapy in localized or oligometastatic non-small cell lung cancer (KOMPASSneoOP). (March 2022)

7. Complete metabolic response in patients with advanced non-small cell lung cancer with prolonged response to immune checkpoint inhibitor therapy. Issue 3 (31st March 2021)

8. Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial. Issue 10 (October 2022)

9. Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study . (29th April 2022)

10. Complete metabolic response in patients with advanced nonsmall cell lung cancer with prolonged response to immune checkpoint inhibitor therapy. Issue 3 (31st March 2021)